1. Introduction
Millions of lives were saved thanks to the discovery of antibiotics in the 1940s. However, with the increasing and sometimes inappropriate use of antibiotics, many microbial strains have begun to adapt and develop resistance to this therapy. In France, as in other industrialized countries, there is an increase in infections caused by bacterial strains that are multi-resistant to antibiotics, particularly nosocomial infections. Infections caused by multi-antibiotic-resistant microbes are difficult, if not impossible, to cure. Researchers are currently pursuing two main avenues to solve the problem: (i) the development of new, effective antibiotics, and (ii) the elaboration of an alternative to antibiotics. The development of new antibiotics is particularly time-consuming and costly. What's more, bacteria often become resistant to them soon after they have been marketed. At present, very...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Introduction
Bibliography
Websites
In 2002, the European Union set up the 6th Framework Program called Nano2Life. http://www.nano2life.org
Among the national networks, we should mention "C'NANO Île-de-France". http://www.cnanoidf.org/
Other advisor leads.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference